
  
    
      
        Background_NNP
        Heterotrimeric_NNP G_NNP proteins_NNS couple_NN agonist-activated_JJ
        heptahelical_JJ receptors_NNS to_TO a_DT variety_NN of_IN effector_NN responses_NNS ._.
        For_IN the_DT most_JJS part_NN ,_, this_DT signaling_VBG activity_NN takes_VBZ place_NN at_IN
        the_DT plasma_NN membranes_NNS of_IN cells_NNS ._. However_RB ,_, G_NNP proteins_NNS have_VBP
        been_VBN detected_VBN at_IN a_DT variety_NN of_IN subcellular_NN locations_NNS and_CC
        have_VBP been_VBN implicated_VBN in_IN numerous_JJ membrane_NN trafficking_NN
        activities_NNS [_NN 1_CD 2_CD ]_NN ._. This_DT suggests_VBZ that_IN distinct_JJ ,_, though_IN
        not_RB yet_RB determined_VBN ,_, mechanisms_NNS exist_VBP to_TO target_VB G_NNP protein_NN
        subunits_NNS to_TO subcellular_NN locations_NNS other_JJ than_IN plasma_NN
        membranes_NNS (_( PM_NNP )_) ._. Furthermore_RB ,_, post-transcriptional_JJ or_CC
        post-translational_JJ modifications_NNS may_MD play_VB a_DT role_NN in_IN
        directing_VBG a_DT G_NNP protein_NN subunit_NN to_TO a_DT specific_JJ intracellular_NN
        location_NN ._.
        Unique_NNP subcellular_NN localization_NN has_VBZ been_VBN observed_VBN for_IN a_DT
        novel_NN alternative_NN spliced_JJ form_NN of_IN the_DT G_NNP protein_NN α_NN subunit_NN
        (_( Gα_NNP )_) ,_, α_NN 
        i_NNP 2_CD [_NN 3_CD ]_NN ._. This_DT α_NN 
        i_NNP 2_CD splice_NN variant_NN ,_, termed_VBD sα_NN 
        i_NNP 2_CD ,_, contains_VBZ a_DT novel_NN 35_CD amino_JJ acid_NN
        sequence_NN that_WDT replaces_VBZ the_DT C-_NNP terminal_NN 24_CD amino_JJ acids_NNS of_IN α_NN 
        i_NNP 2_CD [_NN 3_CD ]_NN ._. sα_NN 
        i_NNP 2_CD has_VBZ been_VBN observed_VBN to_TO localize_NN to_TO
        Golgi_NNP membranes_NNS and_CC other_JJ intracellular_NN membranes_NNS [_NN 3_CD 4_CD ]_NN ;_:
        in_IN contrast_NN ,_, wild_JJ type_NN α_NN 
        i_NNP 2_CD is_VBZ typically_RB found_VBN at_IN PM_NNP ._. Based_VBN on_IN
        this_DT unique_JJ localization_NN of_IN sα_NN 
        i_NNP 2_CD ,_, a_DT prominent_JJ role_NN in_IN membrane_NN
        trafficking_NN has_VBZ been_VBN proposed_VBN for_IN this_DT subunit_NN [_NN 3_CD ]_NN ._.
        However_RB ,_, no_DT report_NN to_TO date_NN has_VBZ supported_VBN a_DT functional_JJ role_NN
        for_IN sα_NN 
        i_NNP 2_CD in_IN vesicular_NN transport_NN ,_, although_IN a_DT
        variety_NN of_IN functional_JJ assays_NNS have_VBP implicated_VBN other_JJ Gα_NNP ,_,
        including_VBG α_NN 
        s_VBZ and_CC α_NN 
        i_NNP 3_CD ,_, in_IN vesicle_NN trafficking_NN pathways_NNS [_NN 1_CD
        2_CD ]_NN ._.
        In_IN spite_NN of_IN its_PRP$ unknown_JJ functional_JJ significance_NN ,_, sα_NN 
        i_NNP 2_CD provides_VBZ a_DT potential_JJ model_NN for_IN
        studying_VBG mechanisms_NNS of_IN subcellular_NN localization_NN of_IN Gα_NNP ._.
        Clearly_RB ,_, some_DT aspect_NN of_IN the_DT novel_NN splicing_VBG is_VBZ responsible_JJ
        for_IN the_DT difference_NN in_IN subcellular_NN targeting_VBG of_IN sα_NN 
        i_NNP 2_CD (_( 
        i_NNP ._. e_SYM ._. ,_, Golgi_NNP and_CC intracellular_NN
        membranes_NNS )_) compared_VBN to_TO wild_JJ type_NN α_NN 
        i_NNP 2_CD (_( 
        i_NNP ._. e_SYM ._. ,_, PM_NNP )_) ._. To_TO address_VB the_DT mechanism_NN
        of_IN subcellular_NN localization_NN of_IN sα_NN 
        i_NNP 2_CD ,_, two_CD hypotheses_NNS were_VBD tested_VBN herein_NN ._.
        First_LS ,_, the_DT possibility_NN was_VBD tested_VBN that_IN the_DT novel_NN 35_CD amino_JJ
        acid_NN sequence_NN found_VBD at_IN the_DT C-_NNP terminus_JJ of_IN sα_NN 
        i_NNP 2_CD functions_NNS as_IN a_DT specific_JJ Golgi_NNP or_CC
        intracellular_NN membrane_NN targeting_VBG motif_NN ._. A_DT second_JJ
        possibility_NN was_VBD suggested_VBN by_IN considering_VBG the_DT location_NN of_IN
        the_DT splice_NN site_NN ._. Several_JJ studies_NNS have_VBP shown_VBN that_IN deletions_NNS
        or_CC amino_JJ acid_NN substitutions_NNS in_IN the_DT extreme_JJ C-_NNP terminal_NN
        region_NN of_IN Gα_NNP creates_VBZ a_DT protein_NN defective_JJ in_IN
        guanine-nucleotide_JJ binding_JJ [_NN 5_CD 6_CD 7_CD 8_CD 9_CD 10_CD ]_NN ._. Rapid_NNP release_NN
        of_IN guanine-nucleotides_JJ can_MD result_VB in_IN an_DT unstable_JJ Gα_NNP [_NN 9_CD 10_CD
        ]_NN ._. This_DT leads_VBZ to_TO the_DT prediction_NN that_DT sα_NN 
        i_NNP 2_CD is_VBZ also_RB unstable_JJ due_NN to_TO a_DT disruption_NN
        in_IN the_DT structure_NN of_IN its_PRP$ C-_NNP terminus_JJ caused_VBD by_IN the_DT novel_NN
        splice_NN sequence_NN ._. Thus_RB ,_, the_DT second_JJ possibility_NN is_VBZ that_DT
        failure_NN of_IN sα_NN 
        i_NNP 2_CD to_TO localize_NN at_IN the_DT PM_NNP but_CC instead_RB
        localize_NN at_IN intracellular_NN membranes_NNS is_VBZ the_DT result_NN of_IN a_DT
        general_JJ defect_NN in_IN protein_NN stability_NN ._. Results_NNS presented_VBD
        herein_NN are_VBP consistent_JJ with_IN this_DT second_JJ hypothesis_NNS ._.
      
      
        Results_NNS
        α_NN 
        i_NNP 2_CD and_CC sα_NN 
        i_NNP 2_CD differ_VB only_RB at_IN their_PRP$ extreme_JJ
        C-_NNP termini_NN ._. Alternative_NNP splicing_VBG results_NNS in_IN a_DT novel_NN 35_CD amino_JJ
        acids_NNS in_IN sα_NN 
        i_NNP 2_CD that_WDT replace_VBP the_DT C-_NNP terminal_NN 24_CD amino_JJ
        acids_NNS of_IN α_NN 
        i_NNP 2_CD (_( Figure_NN 1_LS )_) ._. In_IN the_DT studies_NNS presented_VBN
        here_RB ,_, both_DT α_NN 
        i_NNP 2_CD and_CC sα_NN 
        i_NNP 2_CD contain_VB an_DT internal_JJ EE_NNP epitope_NN ,_, as_IN
        used_VBN previously_RB for_IN α_NN 
        i_NNP 2_CD [_NN 11_CD 12_CD ]_NN ._. The_DT use_NN of_IN the_DT EE_NNP epitope_NN
        allows_VBZ the_DT direct_JJ comparison_NN of_IN subcellular_NN localization_NN
        and_CC expression_NN of_IN α_NN 
        i_NNP 2_CD and_CC sα_NN 
        i_NNP 2_CD ,_, and_CC facilitates_NNS immunoprecipitation_NN
        of_IN the_DT two_CD expressed_VBD proteins_NNS ._. This_DT is_VBZ essential_JJ since_IN
        suitable_JJ antibodies_NNS to_TO detect_VB and_CC immuno-isolate_JJ sα_NN 
        i_NNP 2_CD are_VBP not_RB readily_RB available_JJ ._. Attempts_NNS
        to_TO use_VB a_DT previously_RB described_VBN polyclonal_NN antibody_NN directed_VBN
        against_IN the_DT C-_NNP terminus_JJ of_IN sα_NN 
        i_NNP 2_CD [_NN 3_CD 4_CD ]_NN were_VBD unsatisfactory_NN in_IN our_PRP$
        hands_NNS ._. In_IN particular_JJ ,_, attempts_VBZ to_TO detect_VB endogenous_JJ sα_NN 
        i_NNP 2_CD by_IN immunofluorescence_NN failed_VBD due_JJ to_TO
        faint_VB detection_NN that_WDT showed_VBD drastically_RB different_JJ patterns_NNS
        of_IN staining_VBG depending_VBG upon_IN fixation_NN technique_NN ._.
        The_DT subcellular_NN localization_NN of_IN expressed_VBD α_NN 
        i_NNP 2_CD and_CC sα_NN 
        i_NNP 2_CD was_VBD compared_VBN in_IN COS_NNP and_CC BHK_NNP cells_NNS
        (_( Figure_NN 2_LS )_) ._. In_IN both_DT cell_NN types_NNS ,_, α_NN 
        i_NNP 2_CD was_VBD detected_VBN at_IN cellular_JJ plasma_NN
        membranes_NNS as_IN highlighted_VBN by_IN bright_JJ staining_VBG at_IN the_DT cell_NN
        periphery_NN (_( Figure_NN 2_CD Aand_NNP 2_CD C_NNP )_) ._. In_IN contrast_NN ,_, sα_NN 
        i_NNP 2_CD was_VBD not_RB detected_VBN at_IN plasma_NN membranes_NNS ,_,
        but_CC instead_RB typically_RB displayed_VBD an_DT intracellular_NN and_CC
        perinuclear_NN staining_VBG pattern_NN (_( Figure_NN 2_CD Band_NNP 2_CD D_NNP )_) ,_, consistent_JJ
        with_IN localization_NN to_TO intracellular_NN membranes_NNS as_RB previously_RB
        described_VBD [_NN 3_CD 4_CD ]_NN ._. The_DT subcellular_NN localization_NN of_IN sα_NN 
        i_NNP 2_CD showed_VBD overlap_VB in_IN immunofluorescent_NN
        staining_VBG with_IN the_DT Golgi_NNP protein_NN ,_, β-_NN COP_NNP (_( Figure_NN 3_CD Aand_NNP 3_CD B_NNP )_)
        and_CC the_DT endoplasmic_JJ reticulum_NN protein_NN PDI_NNP (_( Figure_NN 3_CD Cand_NNP
        3_CD D_NNP )_) ;_: localization_NN of_IN sα_NN 
        i_NNP 2_CD exclusively_RB to_TO Golgi_NNP was_VBD not_RB
        observed_VBN ,_, even_RB at_IN the_DT lowest_JJS levels_NNS of_IN detection_NN ._.
        Subcellular_NNP fractionation_NN confirmed_VBD that_DT sα_NN 
        i_NNP 2_CD was_VBD localized_JJ ,_, at_IN least_JJS partly_RB ,_, to_TO
        membranes_NNS (_( Figure_NN 2_CD E_NNP )_) ._. After_IN lysis_NNS of_IN cells_NNS in_IN hypotonic_JJ
        buffer_NN followed_VBN by_IN high-speed_JJ centrifugation_NN ,_, α_NN 
        i_NNP 2_CD was_VBD found_VBN predominantly_RB in_IN the_DT
        particulate_NN fraction_NN from_IN COS_NNP (_( Figure_NN 2_CD E_NNP ,_, lanes_NNS 3_CD and_CC 4_LS )_) or_CC
        BHK_NNP cells_NNS (_( Figure_NN 2_CD E_NNP ,_, lanes_NNS 9_CD and_CC 10_CD )_) ._. A_DT majority_NN of_IN sα_NN 
        i_NNP 2_CD was_VBD also_RB detected_VBN in_IN the_DT particulate_NN
        fraction_NN from_IN both_DT COS_NNP (_( Figure_NN 2_CD E_NNP ,_, lanes_NNS 5_CD and_CC 6_CD )_) and_CC BHK_NNP
        cells_NNS (_( Figure_NN 2_CD E_NNP ,_, lanes_NNS 11_CD and_CC 12_CD )_) ,_, although_IN some_DT was_VBD also_RB
        found_VBN in_IN the_DT soluble_JJ fraction_NN ._. As_IN a_DT comparison_NN ,_, a_DT
        non-palmitoylated_JJ mutant_JJ of_IN α_NN 
        q_NN ,_, in_IN which_WDT cysteines_NNS 9_CD and_CC 10_CD have_VBP
        been_VBN substituted_VBN with_IN serines_NNS ,_, is_VBZ found_VBN predominantly_RB in_IN
        the_DT soluble_JJ fraction_NN (_( Figure_NN 2_CD E_NNP ,_, lanes_NNS 7_CD and_CC 8_CD )_) ,_, as_IN
        described_VBN previously_RB [_NN 13_CD ]_NN ._. Surprisingly_RB ,_, in_IN comparison_NN
        to_TO α_NN 
        i_NNP 2_CD ,_, sα_NN 
        i_NNP 2_CD was_VBD always_RB detected_VBN in_IN fewer_JJR cells_NNS ,_,
        by_IN immunofluorescence_NN analysis_NN ,_, and_CC showed_VBD lower_JJR levels_NNS of_IN
        protein_NN expression_NN ,_, by_IN western_JJ blot_NN analysis_NN of_IN subcellular_NN
        fractions_NNS (_( Figure_NN 2_CD E_NNP )_) or_CC whole_JJ cell_NN lysates_NNS (_( not_RB shown_VBN )_) ._.
        These_DT expression_NN differences_NNS suggested_VBD that_DT sα_NN 
        i_NNP 2_CD was_VBD either_CC less_RBR efficiently_RB expressed_VBD
        or_CC more_RBR rapidly_RB degraded_JJ compared_VBN to_TO α_NN 
        i_NNP 2_CD ,_, as_IN described_VBN below_IN ._.
        The_DT C-_NNP terminal_NN 35_CD amino_JJ acids_NNS of_IN sα_NN 
        i_NNP 2_CD ,_, which_WDT replace_VBP the_DT C-_NNP terminal_NN 24_CD
        amino_JJ acids_NNS of_IN α_NN 
        i_NNP 2_CD (_( Figure_NN 1_LS )_) ,_, have_VBP been_VBN proposed_VBN to_TO
        function_VB as_IN a_DT Golgi_NNP targeting_VBG signal_NN [_NN 3_CD 4_CD ]_NN ._. To_TO test_VB the_DT
        potential_JJ importance_NN of_IN this_DT C-_NNP terminal_NN region_NN in_IN
        localization_NN of_IN sα_NN 
        i_NNP 2_CD to_TO intracellular_NN membranes_NNS and_CC
        prevention_NN of_IN sα_NN 
        i_NNP 2_CD from_IN localizing_VBG to_TO PM_NNP ,_, a_DT deletion_NN
        mutant_JJ of_IN α_NN 
        i_NNP 2_CD was_VBD constructed_VBN consisting_VBG of_IN amino_JJ
        acids_NNS 1_CD -_: 331_CD ._. In_IN sα_NN 
        i_NNP 2_CD ,_, the_DT C-_NNP terminal_NN splice_NN occurs_VBZ just_RB
        after_IN amino_JJ acid_NN 331_CD (_( Figure_NN 1_LS )_) ,_, and_CC thus_RB the_DT novel_NN 35_CD
        amino_JJ acid_NN splice_NN sequence_NN is_VBZ removed_VBN in_IN α_NN 
        i_NNP 2_CD (_( 1_CD -_: 331_CD )_) ._. Immunofluorescence_NNP
        microscopy_NN indicates_VBZ that_DT α_NN 
        i_NNP 2_CD (_( 1_CD -_: 331_CD )_) (_( Figure_NN 4_CD B_NNP )_) displays_VBZ a_DT
        subcellular_NN localization_NN pattern_NN very_RB similar_JJ to_TO sα_NN 
        i_NNP 2_CD (_( Figure_NN 4_CD A_DT )_) ._. This_DT result_NN is_VBZ
        consistent_JJ with_IN the_DT alternative_JJ hypothesis_NNS that_IN a_DT
        disruption_NN of_IN α_NN 
        i_NNP 2_CD at_IN the_DT C-_NNP terminus_JJ creates_VBZ a_DT protein_NN
        unable_JJ to_TO localize_NN at_IN the_DT PM_NNP ._.
        If_IN the_DT unique_JJ C-_NNP terminal_NN 35_CD amino_JJ acid_NN sequence_NN of_IN sα_NN 
        i_NNP 2_CD functions_NNS as_IN a_DT Golgi_NNP targeting_VBG
        signal_NN ,_, it_PRP is_VBZ important_JJ to_TO test_VB whether_IN it_PRP is_VBZ sufficient_JJ to_TO
        target_VB a_DT heterologous_JJ protein_NN to_TO intracellular_NN membranes_NNS ._.
        When_WRB the_DT 35_CD amino_JJ acid_NN sequence_NN was_VBD fused_JJ to_TO the_DT C-_NNP terminus_JJ
        of_IN GFP_NNP (_( GFP-sα_NNP 
        i_NNP 2_CD 35_CD aa_NN )_) ,_, this_DT unique_JJ sα_NN 
        i_NNP 2_CD sequence_NN failed_VBD to_TO direct_VB GFP_NNP to_TO
        intracellular_NN membranes_NNS (_( Figure_NN 5_CD B_NNP )_) ;_: GFP-sα_NNP 
        i_NNP 2_CD 35_CD aa_NN was_VBD diffusely_RB distributed_VBN
        throughout_IN the_DT cytoplasm_NN and_CC nucleus_NN ,_, similar_JJ to_TO what_WP is_VBZ
        observed_VBN for_IN GFP_NNP alone_RB (_( Figure_NN 5_CD A_DT )_) ._. On_IN the_DT other_JJ hand_NN ,_, when_WRB
        the_DT first_JJ ten_CD amino_JJ acids_NNS of_IN α_NN 
        i_NNP 2_CD are_VBP fused_JJ to_TO GFP_NNP to_TO create_VB α_NN 
        i_NNP 2_CD (_( 1_CD -_: 10_CD )_) -_: GFP_NNP ,_, fluorescence_NN is_VBZ detected_VBN
        strongly_RB at_IN the_DT PM_NNP (_( Figure_NN 5_CD C_NNP )_) ,_, indicating_VBG the_DT N-_NNP terminus_JJ
        of_IN α_NN 
        i_NNP 2_CD ,_, which_WDT contains_VBZ the_DT sites_NNS for_IN
        myristoylation_NN and_CC palmitoylation_NN [_NN 14_CD ]_NN ,_, can_MD be_VB
        sufficient_JJ for_IN directing_VBG PM_NNP localization_NN of_IN a_DT normally_RB
        cytosolic_JJ protein_NN ._. In_IN agreement_NN with_IN these_DT results_NNS ,_, the_DT sα_NN 
        i_NNP 2_CD C-_NNP terminal_NN sequence_NN failed_VBD to_TO
        redirect_NN the_DT localization_NN of_IN a_DT secreted_JJ or_CC a_DT nuclear_JJ
        protein_NN [_NN 4_CD ]_NN ._. Thus_RB ,_, not_RB only_RB is_VBZ the_DT unique_JJ sα_NN 
        i_NNP 2_CD sequence_NN unable_JJ to_TO override_VB other_JJ
        localization_NN signals_NNS ,_, it_PRP is_VBZ unable_JJ to_TO target_VB a_DT cytoplasmic_JJ
        protein_NN to_TO intracellular_NN membranes_NNS ._. These_DT results_NNS are_VBP
        consistent_JJ with_IN a_DT lack_NN of_IN a_DT specific_JJ role_NN for_IN the_DT sα_NN 
        i_NNP 2_CD sequence_NN in_IN Golgi_NNP membrane_NN
        targeting_VBG ._.
        The_DT above_IN experimental_JJ results_NNS failed_VBD to_TO support_VB the_DT
        hypothesis_NNS that_IN the_DT unique_JJ 35_CD amino_JJ acid_NN sequence_NN from_IN sα_NN 
        i_NNP 2_CD serves_VBZ as_IN a_DT specific_JJ Golgi_NNP or_CC
        intracellular_NN membrane_NN targeting_VBG motif_NN ._. Thus_RB ,_, the_DT following_VBG
        experiments_NNS concentrated_VBN on_IN addressing_VBG the_DT alternative_JJ
        hypothesis_NNS :_: sα_NN 
        i_NNP 2_CD is_VBZ unstable_JJ and_CC rapidly_RB degraded_JJ due_NN
        to_TO disruptions_NNS in_IN the_DT C-_NNP terminus_JJ ,_, and_CC such_JJ instability_NN
        results_NNS in_IN a_DT failure_NN of_IN sα_NN 
        i_NNP 2_CD to_TO reach_VB its_PRP$ proper_JJ place_NN at_IN the_DT
        PM_NNP ._.
        The_DT ability_NN of_IN α_NN 
        i_NNP 2_CD and_CC sα_NN 
        i_NNP 2_CD to_TO undergo_VB N-_NNP terminal_NN lipid_NN
        modifications_NNS was_VBD compared_VBN ._. Myristoylation_NNP occurs_VBZ
        co-translationally_JJ at_IN the_DT extreme_JJ N-_NNP terminal_NN glycine_NN ,_, while_IN
        palmitoylation_NN occurs_VBZ post-translationally_JJ at_IN a_DT cysteine_NN
        immediately_RB after_IN the_DT myristoylated_JJ glycine_NN [_NN 15_CD ]_NN ._. The_DT
        subcellular_NN site_NN where_WRB palmitoylation_NN occurs_VBZ has_VBZ not_RB been_VBN
        well_RB defined_VBN ,_, although_IN in_IN one_CD model_NN palmitoylation_NN occurs_VBZ
        at_IN the_DT PM_NNP [_NN 16_CD ]_NN ._. Cells_NNP expressing_VBG α_NN 
        i_NNP 2_CD or_CC sα_NN 
        i_NNP 2_CD were_VBD metabolically_RB labeled_VBN with_IN
        3_CD H-_NNP palmitate_NN or_CC 3_CD H-_NNP myristate_NN ._. α_NN 
        i_NNP 2_CD and_CC sα_NN 
        i_NNP 2_CD were_VBD immunoprecipitated_JJ from_IN cell_NN
        extracts_NNS ,_, and_CC incorporation_NN of_IN radio-label_JJ was_VBD analyzed_VBN by_IN
        SDS-PAGE_NNP followed_VBN by_IN fluorography_NN (_( Figure_NN 6_CD A_DT )_) ._. No_DT
        palmitoylation_NN of_IN sα_NN 
        i_NNP 2_CD was_VBD detected_VBN (_( Figure_NN 6_CD A_DT ,_, lane_NN 3_LS )_) ,_,
        although_IN α_NN 
        i_NNP 2_CD was_VBD strongly_RB palmitoylated_JJ (_( Figure_NN
        6_CD A_DT ,_, lane_NN 2_LS )_) ._. In_IN contrast_NN ,_, both_DT α_NN 
        i_NNP 2_CD and_CC sα_NN 
        i_NNP 2_CD incorporated_VBN similar_JJ levels_NNS or_CC
        myristate_NN (_( Figure_NN 6_CD A_DT ,_, lanes_NNS 5_CD and_CC 6_CD )_) ._. The_DT similar_JJ level_NN of_IN
        myristoylation_NN was_VBD particularly_RB surprising_JJ since_IN total_JJ sα_NN 
        i_NNP 2_CD protein_NN was_VBD much_RB lower_JJR than_IN α_NN 
        i_NNP 2_CD as_IN determined_VBN by_IN immunoblotting_VBG of_IN
        the_DT immunoprecipitates_NNS (_( Figure_NN 6_CD B_NNP ,_, compare_VB lanes_NNS 5_CD and_CC 6_CD )_) ._.
        Myristoylation_NNP is_VBZ a_DT co-translational_JJ modification_NN ,_, and_CC
        levels_NNS of_IN radio-labeling_JJ should_MD thus_RB reflect_VB synthesis_NN of_IN
        new_JJ protein_NN ._. Accordingly_RB ,_, the_DT myristoylation_NN results_NNS
        (_( Figure_NN 6_CD Aand_NNP 6_CD B_NNP ,_, lanes_NNS 5_CD and_CC 6_CD )_) strongly_RB suggested_VBD that_DT α_NN 
        i_NNP 2_CD and_CC sα_NN 
        i_NNP 2_CD are_VBP translated_VBN equally_RB well_RB ,_, as_IN
        evidenced_VBN by_IN similar_JJ levels_NNS of_IN radiolabeled_JJ myristate_NN
        incorporation_NN during_IN the_DT labeling_VBG period_NN ,_, but_CC sα_NN 
        i_NNP 2_CD is_VBZ more_RBR rapidly_RB degraded_JJ ,_, as_IN seen_VBN by_IN
        reduced_VBN steady-state_JJ levels_NNS of_IN immunoprecipitated_JJ protein_NN ._.
        The_DT lack_NN of_IN palmitoylation_NN of_IN sα_NN 
        i_NNP 2_CD is_VBZ consistent_JJ with_IN at_IN least_JJS two_CD ,_, not_RB
        necessarily_RB mutually_RB exclusive_JJ ,_, possibilities_NNS ._. sα_NN 
        i_NNP 2_CD may_MD fail_VB to_TO undergo_VB palmitoylation_NN
        because_IN it_PRP is_VBZ not_RB stable_JJ long_RB enough_RB for_IN post-translational_JJ
        palmitoylation_NN to_TO occur_VB or_CC because_IN it_PRP fails_VBZ to_TO reach_VB a_DT PM_NNP
        site_NN of_IN palmitoylation_NN ._. Alternatively_RB ,_, the_DT novel_JJ C-_NNP terminal_NN
        sequence_NN of_IN sα_NN 
        i_NNP 2_CD may_MD somehow_RB prevent_VB direct_JJ
        recognition_NN by_IN a_DT palmitoyl_NN transferase_NN ._.
        Cells_NNP expressing_VBG high_JJ levels_NNS of_IN sα_NN 
        i_NNP 2_CD ,_, and_CC to_TO a_DT much_RB lesser_JJR extent_NN α_NN 
        i_NNP 2_CD ,_, often_RB displayed_VBN very_RB bright_JJ
        intracellular_NN accumulations_NNS of_IN sα_NN 
        i_NNP 2_CD as_IN visualized_JJ by_IN immunofluorescence_NN ._.
        These_DT large_JJ spots_NNS were_VBD reminiscent_NN of_IN recently_RB described_VBD
        aggresomes_NNS ,_, accumulations_NNS of_IN misfolded_JJ protein_NN that_WDT are_VBP
        being_VBG targeted_VBN for_IN proteasome-dependent_JJ degradation_NN [_NN 17_CD 18_CD
        ]_NN ._. This_DT observation_NN suggested_VBD the_DT possibility_NN that_DT
        intracellular_NN localization_NN of_IN sα_NN 
        i_NNP 2_CD may_MD reflect_VB targeting_VBG to_TO a_DT
        proteasome-dependent_JJ degradative_JJ pathway_NN ._. To_TO test_VB this_DT idea_NN
        further_RBR ,_, cells_NNS expressing_VBG α_NN 
        i_NNP 2_CD or_CC sα_NN 
        i_NNP 2_CD were_VBD treated_VBN with_IN the_DT proteasome_NN
        inhibitor_NN acetyl-leucyl-leucyl-norleucinal_JJ (_( ALLN_NNP )_) and_CC
        changes_NNS in_IN localization_NN of_IN the_DT α_NN subunit_NN were_VBD analyzed_VBN by_IN
        immunofluorescence_NN (_( Figure_NN 7_CD )_) ._. After_IN 1_CD h_NN treatment_NN with_IN
        ALLN_NNP ,_, α_NN 
        i_NNP 2_CD localization_NN is_VBZ relatively_RB unaffected_JJ
        (_( Figure_NN 7_CD C_NNP )_) ,_, but_CC sα_NN 
        i_NNP 2_CD begins_VBZ to_TO show_VB a_DT slight_JJ increase_NN in_IN
        distinct_JJ intracellular_NN accumulations_NNS (_( Figure_NN 7_CD D_NNP )_) ._. At_IN 4_CD h_NN
        ALLN_NNP treatment_NN ,_, many_JJ cells_NNS expressing_VBG α_NN 
        i_NNP 2_CD display_NN a_DT decrease_NN in_IN PM_NNP localization_NN
        and_CC an_DT increase_NN in_IN intracellular_NN staining_VBG (_( Figure_NN 7_CD E_NNP )_) ._. α_NN 
        i_NNP 2_CD is_VBZ typically_RB seen_VBN in_IN large_JJ bright_JJ
        spots_NNS and_CC in_IN a_DT perinuclear_NN /_NN intracellular_NN membrane_NN staining_VBG
        pattern_NN after_IN incubation_NN of_IN cells_NNS for_IN 4_CD h_NN with_IN ALLN_NNP ._. In_IN
        fact_NN ,_, the_DT localization_NN pattern_NN of_IN α_NN 
        i_NNP 2_CD after_IN 4_CD h_NN incubation_NN with_IN ALLN_NNP
        (_( Figure_NN 7_CD E_NNP )_) is_VBZ similar_JJ to_TO the_DT observed_VBN localization_NN of_IN sα_NN 
        i_NNP 2_CD in_IN the_DT absence_NN or_CC presence_NN of_IN ALLN_NNP
        treatment_NN (_( Figure_NN 7_CD B_NNP ,_, 7_CD D_NNP ,_, and_CC 7_CD F_NN )_) ._. At_IN 8_CD h_NN treatment_NN with_IN
        ALLN_NNP ,_, both_DT α_NN 
        i_NNP 2_CD (_( Figure_NN 7_CD G_NNP )_) and_CC sα_NN 
        i_NNP 2_CD (_( Figure_NN 7_CD H_NNP )_) are_VBP detected_VBN almost_RB
        exclusively_RB as_IN a_DT large_JJ bright_JJ spot_NN in_IN each_DT expressing_VBG cell_NN ._.
        Similar_JJ results_NNS were_VBD obtained_VBN using_VBG another_DT proteasome_NN
        inhibitor_NN ,_, MG-_NNP 132_CD ._. Interestingly_RB ,_, ALLN_NNP treatment_NN was_VBD
        relatively_RB ineffective_JJ at_IN promoting_VBG accumulation_NN of_IN
        overexpressed_JJ α_NN 
        s_VBZ in_IN aggresome-like_JJ structures_NNS (_( not_RB
        shown_VBN )_) ._. Thus_RB ,_, the_DT results_NNS of_IN Figure_NN 7_CD are_VBP consistent_JJ with_IN
        the_DT proposal_NN that_IN the_DT intracellular_NN localization_NN of_IN sα_NN 
        i_NNP 2_CD is_VBZ due_JJ to_TO its_PRP$ targeting_VBG to_TO a_DT
        degradative_JJ pathway_NN ,_, a_DT pathway_NN shared_VBN by_IN α_NN 
        i_NNP 2_CD ._.
        The_DT subcellular_NN localization_NN of_IN sα_NN 
        i_NNP 2_CD was_VBD compared_VBN to_TO α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP ._. This_DT alanine_NN to_TO serine_NN
        mutation_NN in_IN the_DT C-_NNP terminal_NN region_NN of_IN α_NN 
        i_NNP 1_CD (_( A_DT 326_CD S_NNP )_) and_CC α_NN 
        s_VBZ (_( A_DT 366_CD S_NNP )_) has_VBZ been_VBN shown_VBN to_TO greatly_RB
        accelerate_VB GDP_NNP release_NN ,_, to_TO accelerate_VB irreversible_JJ
        inactivation_NN 
        in_IN vitro_NN ,_, and_CC to_TO cause_VB rapid_JJ
        turnover_NN of_IN the_DT α_NN subunit_NN in_IN cultured_JJ cells_NNS [_NN 9_CD 10_CD ]_NN ._.
        Thus_RB ,_, if_IN the_DT observed_VBN intracellular_NN localization_NN of_IN sα_NN 
        i_NNP 2_CD is_VBZ caused_VBN by_IN instability_NN of_IN the_DT
        protein_NN due_JJ to_TO disruptions_NNS at_IN its_PRP$ C-_NNP terminus_JJ ,_, then_RB it_PRP
        follows_VBZ that_DT α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP should_MD show_VB a_DT similar_JJ pattern_NN
        of_IN localization_NN ._. Indeed_RB ,_, immunofluorescence_NN microscopy_NN
        revealed_VBD a_DT pronounced_VBN intracellular_NN distribution_NN for_IN α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP (_( Figure_NN 8_CD E_NNP )_) ._. In_IN addition_NN to_TO
        intracellular_NN membrane_NN localization_NN similar_JJ to_TO sα_NN 
        i_NNP 2_CD (_( Figure_NN 8_CD C_NNP )_) ,_, α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP was_VBD detected_VBN weakly_RB but_CC
        consistently_RB at_IN the_DT PM_NNP ._. It_PRP seems_VBZ likely_JJ that_IN the_DT C-_NNP terminal_NN
        disruption_NN of_IN sα_NN 
        i_NNP 2_CD (_( replacing_VBG the_DT 24_CD C-_NNP terminal_NN amino_JJ
        acids_NNS )_) is_VBZ a_DT more_RBR severe_JJ disruption_NN than_IN the_DT A_DT 327_CD S_NNP
        substitution_NN ._. Thus_RB ,_, the_DT similarity_NN in_IN localization_NN of_IN sα_NN 
        i_NNP 2_CD and_CC α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP bolsters_VBZ the_DT idea_NN that_DT
        mislocalization_NN of_IN sα_NN 
        i_NNP 2_CD is_VBZ caused_VBN by_IN its_PRP$ inherent_JJ
        instability_NN ._.
        G_NNP protein_NN βγ_NN subunits_NNS can_MD stabilize_VB wild_JJ type_NN and_CC
        alanine_NN to_TO serine_NN mutant_JJ α_NN subunits_NNS 
        in_IN vitro_NN [_NN 10_CD ]_NN ._. Thus_RB ,_, the_DT effect_NN of_IN
        βγ_NN co-expression_JJ on_IN subcellular_NN localization_NN of_IN α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP and_CC sα_NN 
        i_NNP 2_CD was_VBD tested_VBN ._. α_NN 
        i_NNP 2_CD localizes_NNS to_TO the_DT PM_NNP efficiently_RB when_WRB
        expressed_VBD alone_RB (_( Figure_NN 8_CD A_DT )_) or_CC when_WRB co-expressed_JJ with_IN βγ_NN
        (_( Figure_NN 8_CD B_NNP )_) ._. sα_NN 
        i_NNP 2_CD shows_VBZ a_DT dramatic_JJ change_NN in_IN
        localization_NN when_WRB co-expressed_JJ with_IN βγ_NN (_( Figure_NN 8_CD D_NNP )_) ,_,
        displaying_VBG strong_JJ PM_NNP staining_VBG ._. Not_RB only_RB is_VBZ sα_NN 
        i_NNP 2_CD targeted_VBN efficiently_RB to_TO the_DT PM_NNP when_WRB
        co-expressed_JJ with_IN βγ_NN ,_, but_CC βγ_NN co-expression_JJ increases_VBZ
        overall_JJ levels_NNS of_IN transiently_RB expressed_VBD sα_NN 
        i_NNP 2_CD and_CC α_NN 
        i_NNP 2_CD ,_, as_IN determined_VBN by_IN immunoblotting_VBG
        (_( Figure_NN 8_CD G_NNP )_) ,_, and_CC increases_VBZ the_DT number_NN of_IN cells_NNS expressing_VBG
        sα_NN 
        i_NNP 2_CD ,_, as_IN observed_VBN by_IN immunofluorescence_NN
        microscopy_NN (_( not_RB shown_VBN )_) ._. Similarly_RB ,_, co-expression_JJ of_IN βγ_NN
        efficiently_RB promotes_VBZ PM_NNP localization_NN of_IN α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP (_( Figure_NN 8_CD F_NN )_) ._.
        The_DT analysis_NN of_IN the_DT effect_NN of_IN βγ_NN was_VBD extended_VBN by_IN
        examining_VBG the_DT localization_NN of_IN α_NN 
        i_NNP 2_CD or_CC sα_NN 
        i_NNP 2_CD after_IN co-transfection_JJ with_IN βγ_NN and_CC
        after_IN treatment_NN with_IN ALLN_NNP ._. In_IN contrast_NN to_TO Figure_NN 7_CD ,_, a_DT
        marked_VBN difference_NN was_VBD observed_VBN between_IN α_NN 
        i_NNP 2_CD and_CC sα_NN 
        i_NNP 2_CD after_IN ALLN_NNP treatment_NN ._. When_WRB βγ_NN is_VBZ
        co-expressed_JJ with_IN α_NN 
        i_NNP 2_CD ,_, PM_NNP localization_NN of_IN α_NN 
        i_NNP 2_CD is_VBZ observed_VBN ,_, as_IN shown_VBN in_IN Figure_NN 8_CD B_NNP ,_,
        and_CC incubation_NN with_IN ALLN_NNP for_IN 8_CD h_NN shows_VBZ little_JJ effect_NN on_IN PM_NNP
        localization_NN of_IN α_NN 
        i_NNP 2_CD (_( Figure_NN 9_CD A_DT )_) ._. When_WRB βγ_NN is_VBZ co-expressed_JJ
        with_IN sα_NN 
        i_NNP 2_CD ,_, PM_NNP localization_NN of_IN sα_NN 
        i_NNP 2_CD is_VBZ observed_VBN ,_, as_IN shown_VBN in_IN Figure_NN 8_CD D_NNP ,_,
        but_CC incubation_NN with_IN ALLN_NNP for_IN 8_CD h_NN causes_NNS an_DT increase_NN in_IN
        bright_JJ intracellular_NN accumulations_NNS of_IN sα_NN 
        i_NNP 2_CD (_( Figure_NN 9_CD B_NNP )_) ._. Taken_VBN together_RB ,_, results_NNS
        with_IN βγ_NN co-expression_JJ are_VBP consistent_JJ with_IN the_DT ability_NN of_IN βγ_NN
        to_TO promote_VB PM_NNP targeting_VBG of_IN Gα_NNP ,_, and_CC further_JJ suggest_VBP that_DT sα_NN 
        i_NNP 2_CD is_VBZ less_RBR effectively_RB stabilized_VBN than_IN α_NN
        
        i_NNP 2_CD by_IN βγ_NN ,_, as_IN evidenced_VBN by_IN ALLN-induced_NNP
        accumulation_NN in_IN intracellular_NN aggregates_NNS (_( Figure_NN 9_CD B_NNP )_) ._.
        Lastly_NNP ,_, 35_CD S-_NNP methionine_NN pulse-chase_JJ labeling_VBG studies_NNS
        directly_RB confirmed_VBD that_DT sα_NN 
        i_NNP 2_CD was_VBD more_RBR rapidly_RB degraded_JJ than_IN α_NN 
        i_NNP 2_CD (_( Figure_NN 10_CD )_) ._. After_IN transient_JJ
        expression_NN of_IN the_DT α_NN subunits_NNS ,_, cellular_JJ proteins_NNS were_VBD
        radiolabeled_JJ with_IN a_DT brief_JJ pulse_NN of_IN 35_CD S-_NNP methionine_NN followed_VBN
        by_IN a_DT chase_NN ._. Immunoprecipitation_NNP of_IN the_DT α_NN subunit_NN after_IN
        increasing_VBG times_NNS of_IN chase_NN ,_, followed_VBN by_IN SDS-PAGE_NNP and_CC
        fluorography_NN revealed_VBD that_IN radiolabeled_JJ sα_NN 
        i_NNP 2_CD was_VBD rapidly_RB lost_VBN ._. α_NN 
        i_NNP 2_CD consistently_RB displayed_VBD a_DT 3_CD -_: 4_CD fold_VB
        longer_JJR half-life_NN compared_VBN to_TO sα_NN 
        i_NNP 2_CD ,_, while_IN α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP was_VBD intermediate_JJ ._. In_IN the_DT
        experiment_NN presented_VBN in_IN Figure_NN 10_CD ,_, the_DT t_NN 
        1_CD /_NN 2_CD was_VBD determined_VBN to_TO be_VB approximately_RB
        90_CD ,_, 180_CD ,_, and_CC 360_CD min_NN for_IN sα_NN 
        i_NNP 2_CD ,_, α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP ,_, and_CC α_NN 
        i_NNP 2_CD ,_, respectively_RB ._. Although_IN this_DT trend_NN
        was_VBD consistent_JJ ,_, the_DT exact_JJ t_NN 
        1_CD /_NN 2_CD showed_VBD some_DT variability_NN from_IN
        experiment_NN to_TO experiment_NN ,_, probably_RB due_JJ to_TO varying_VBG levels_NNS of_IN
        transient_JJ overexpression_NN ._. It_PRP is_VBZ likely_JJ that_IN the_DT difference_NN
        in_IN turnover_NN of_IN sα_NN 
        i_NNP 2_CD and_CC α_NN 
        i_NNP 2_CD is_VBZ even_RB more_RBR profound_JJ when_WRB the_DT
        proteins_NNS are_VBP expressed_VBN at_IN lower_JJR levels_NNS ._. Consistent_NNP with_IN
        this_DT idea_NN ,_, sα_NN 
        i_NNP 2_CD was_VBD refractory_JJ to_TO stable_JJ expression_NN
        even_RB though_IN cells_NNS stably_RB expressing_VBG α_NN 
        i_NNP 2_CD were_VBD easily_RB selected_VBN (_( not_RB shown_VBN )_) ._. The_DT
        inability_NN to_TO isolate_VB cells_NNS stably_RB expressing_VBG sα_NN 
        i_NNP 2_CD can_MD be_VB attributed_VBN to_TO its_PRP$ rapid_JJ
        degradation_NN ._. Regardless_RB ,_, 35_CD S-_NNP methionine_NN pulse-chase_JJ
        labeling_VBG studies_NNS (_( Figure_NN 10_CD )_) demonstrate_VB that_DT sα_NN 
        i_NNP 2_CD is_VBZ indeed_RB more_RBR rapidly_RB degraded_JJ than_IN
        α_NN 
        i_NNP 2_CD ._.
      
      
        Discussion_NNP
        In_IN addition_NN to_TO their_PRP$ well_RB characterized_VBN role_NN at_IN the_DT PM_NNP
        in_IN coupling_NN activated_VBN GPCRs_NNP to_TO effector_NN proteins_NNS ,_,
        heterotrimeric_JJ G_NNP proteins_NNS have_VBP been_VBN implicated_VBN in_IN a_DT variety_NN
        of_IN other_JJ cellular_JJ functions_NNS ,_, including_VBG membrane_NN trafficking_NN
        pathways_NNS ._. A_DT splice_NN variant_NN of_IN α_NN 
        i_NNP 2_CD ,_, termed_VBD sα_NN 
        i_NNP 2_CD ,_, has_VBZ been_VBN proposed_VBN as_IN a_DT candidate_NN to_TO
        regulate_VB vesicle_NN transport_NN due_JJ to_TO its_PRP$ localization_NN at_IN
        intracellular_NN membranes_NNS ._. The_DT studies_NNS described_VBD in_IN this_DT
        report_NN were_VBD undertaken_VBN to_TO define_VB mechanisms_NNS that_WDT underlie_VB
        subcellular_NN localization_NN of_IN sα_NN 
        i_NNP 2_CD ._. The_DT novel_NN 35_CD amino_JJ acids_NNS found_VBD in_IN
        sα_NN 
        i_NNP 2_CD appear_VB not_RB to_TO function_VB as_IN a_DT specific_JJ
        Golgi_NNP or_CC endoplasmic_JJ reticulum_NN targeting_VBG sequence_NN ._. Instead_RB ,_,
        the_DT results_NNS in_IN this_DT study_NN support_NN the_DT proposal_NN that_DT sα_NN 
        i_NNP 2_CD fails_VBZ to_TO target_VB to_TO the_DT PM_NNP because_IN it_PRP
        is_VBZ an_DT unstable_JJ protein_NN ._. The_DT following_VBG results_NNS support_VBP this_DT
        hypothesis_NNS :_: 1_LS )_) sα_NN 
        i_NNP 2_CD and_CC α_NN 
        i_NNP 2_CD are_VBP equally_RB labeled_VBN by_IN a_DT pulse_NN of_IN
        3_CD H-_NNP myristate_NN ,_, although_IN much_RB less_JJR sα_NN 
        i_NNP 2_CD protein_NN is_VBZ detected_VBN ;_: 2_LS )_) sα_NN 
        i_NNP 2_CD displays_NNS a_DT propensity_NN to_TO localize_NN to_TO
        potential_JJ aggresome-like_JJ structures_NNS ,_, and_CC this_DT localization_NN
        is_VBZ greatly_RB enhanced_VBN by_IN proteasome_NN inhibitor_NN treatment_NN ;_: 3_LS )_)
        the_DT α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP mutant_JJ ,_, previously_RB shown_VBN to_TO be_VB
        unstable_JJ and_CC defective_JJ in_IN guanine-nucleotide_JJ binding_JJ ,_, shows_VBZ
        a_DT similar_JJ pattern_NN of_IN subcellular_NN localization_NN (_( 
        i_NNP ._. e_SYM ._. ,_, intracellular_NN membranes_NNS rather_RB
        than_IN PM_NNP )_) ;_: 4_LS )_) βγ_NN over-expression_JJ increases_NNS expression_NN of_IN sα_NN 
        i_NNP 2_CD and_CC promotes_VBZ PM_NNP localization_NN of_IN sα_NN 
        i_NNP 2_CD and_CC α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP ,_, but_CC βγ_NN co-expression_JJ does_VBZ not_RB
        prevent_VB sα_NN 
        i_NNP 2_CD localization_NN to_TO potential_JJ
        aggresome-like_JJ structures_NNS when_WRB cells_NNS are_VBP treated_VBN with_IN
        proteasome_NN inhibitors_NNS ;_: and_CC 5_LS )_) pulse-chase_JJ analysis_NN
        indicates_VBZ that_DT sα_NN 
        i_NNP 2_CD is_VBZ rapidly_RB degraded_JJ ._.
        A_DT number_NN of_IN reports_NNS have_VBP demonstrated_VBN that_IN disruptions_NNS
        in_IN the_DT C-_NNP termini_NN of_IN Gα_NNP cause_VB reduced_VBN affinity_NN for_IN
        guanine-nucleotides_JJ and_CC protein_NN instability_NN ._. The_DT C-_NNP terminal_NN
        30_CD amino_JJ acids_NNS of_IN Gα_NNP consist_VBP of_IN the_DT β_NN 6_CD -_: α_NN 5_CD loop_NN ,_, followed_VBN by_IN
        the_DT α_NN 5_CD helix_NN and_CC finally_RB several_JJ amino_JJ acids_NNS of_IN flexible_JJ
        structure_NN (_( Figure_NN 1_LS )_) [_NN 19_CD 20_CD 21_CD ]_NN ._. The_DT β_NN 6_CD -_: α_NN 5_CD loop_NN
        stabilizes_VBZ the_DT guanine_NN ring_NN of_IN bound_VBN GDP_NNP or_CC GTP_NNP ,_, and_CC
        mutations_NNS in_IN this_DT region_NN affect_NN guanine-nucleotide_JJ binding_JJ ._.
        The_DT A_DT 326_CD S_NNP mutation_NN of_IN α_NN 
        i_NNP 1_CD and_CC A_DT 366_CD S_NNP mutation_NN of_IN α_NN 
        s_VBZ (_( cognate_NN to_TO the_DT α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP used_VBD in_IN this_DT study_NN )_) were_VBD shown_VBN
        to_TO cause_VB greatly_RB decreased_VBD affinity_NN for_IN GDP_NNP [_NN 9_CD 10_CD ]_NN ._.
        Defective_NNP binding_JJ of_IN GDP_NNP leads_VBZ to_TO more_JJR Gα_NNP in_IN the_DT empty_JJ
        state_NN (_( no_DT bound_VBN guanine-nucleotide_JJ )_) ,_, and_CC this_DT form_NN of_IN Gα_NNP is_VBZ
        rapidly_RB denatured_JJ 
        in_IN vitro_NN ,_, as_IN shown_VBN for_IN α_NN 
        s_VBZ A_DT 366_CD S_NNP and_CC α_NN 
        i_NNP 1_CD A_DT 326_CD S_NNP [_NN 9_CD 10_CD ]_NN ._. Moreover_RB ,_, α_NN 
        s_VBZ A_DT 366_CD S_NNP was_VBD demonstrated_VBN to_TO undergo_VB
        rapid_JJ degradation_NN (_( t_NN 
        1_CD /_NN 2_CD <_NN 1_CD h_NN )_) in_IN stably_RB transfected_JJ
        cells_NNS [_NN 9_CD ]_NN ._. The_DT same_JJ mutation_NN in_IN α_NN 
        t_NN has_VBZ also_RB been_VBN shown_VBN to_TO greatly_RB
        decrease_VB guanine-nucleotide_JJ binding_JJ [_NN 5_CD 22_CD ]_NN ._. Additional_JJ
        amino_JJ acids_NNS in_IN the_DT critical_JJ β_NN 6_CD -_: α_NN 5_CD loop_NN are_VBP important_JJ for_IN
        maintaining_VBG Gα_NNP integrity_NN [_NN 7_CD ]_NN ._.
        Although_IN the_DT α_NN 5_CD helix_NN (_( Figure_NN 1_LS )_) does_VBZ not_RB directly_RB
        contact_VB the_DT bound_VBN guanine-nucleotide_JJ [_NN 19_CD 20_CD 21_CD ]_NN ,_, it_PRP is_VBZ
        clearly_RB important_JJ for_IN Gα_NNP structure_NN and_CC to_TO maintain_VB the_DT
        proper_JJ orientation_NN of_IN the_DT β_NN 6_CD -_: α_NN 5_CD loop_NN ._. A_DT recent_JJ study_NN
        identified_VBD a_DT number_NN of_IN α_NN 5_CD helix_NN residues_NNS in_IN α_NN 
        t_NN that_IN when_WRB changed_VBN to_TO alanines_NNS
        increased_VBN rates_NNS of_IN guanine-nucleotide_JJ exchange_NN (_( 
        i_NNP ._. e_SYM ._. ,_, decreased_VBD affinity_NN for_IN
        guanine-nucleotides_JJ )_) [_NN 5_CD ]_NN ._. Individual_NNP mutation_NN of_IN amino_JJ
        acids_NNS in_IN α_NN 
        t_NN ,_, cognate_NN to_TO T_NN 330_CD ,_, N_NNP 332_CD ,_, V_NNP 333_CD ,_, F_NN 337_CD in_IN
        α_NN 
        i_NNP 2_CD (_( Figure_NN 1_LS )_) ,_, increased_VBN nucleotide_NN
        exchange_NN rates_NNS [_NN 5_CD ]_NN ._. Two_CD of_IN these_DT critical_JJ amino_JJ acids_NNS ,_,
        N_NNP 332_CD and_CC V_NNP 333_CD in_IN α_NN 
        i_NNP 2_CD ,_, are_VBP in_IN fact_NN the_DT first_JJ two_CD amino_JJ
        acids_NNS that_WDT are_VBP replaced_VBN by_IN the_DT novel_NN splicing_VBG in_IN sα_NN 
        i_NNP 2_CD (_( Figure_NN 1_LS )_) ._. Thus_RB ,_, one_PRP might_MD speculate_VB
        that_IN the_DT novel_NN 35_CD amino_JJ acid_NN sequence_NN in_IN sα_NN 
        i_NNP 2_CD would_MD impair_VB guanine-nucleotide_JJ
        binding_JJ and_CC result_NN in_IN a_DT unstable_JJ protein_NN ._. Unfortunately_RB ,_,
        initial_JJ attempts_NNS to_TO directly_RB show_VB a_DT defect_NN in_IN
        guanine-nucleotide_JJ binding_JJ by_IN sα_NN 
        i_NNP 2_CD ,_, using_VBG a_DT GTPγ_NNP S-_NNP dependent_JJ trypsin_NN
        protection_NN assay_NN [_NN 23_CD ]_NN ,_, were_VBD unsuccessful_JJ due_NN ,_, at_IN least_JJS
        in_IN part_NN ,_, to_TO the_DT inability_NN to_TO solubilize_NN expressed_VBD sα_NN 
        i_NNP 2_CD from_IN membranes_NNS using_VBG a_DT mild_JJ detergent_NN
        (_( 
        e_SYM ._. g_SYM ._. ,_, lubrol_NN /_NN polyoxyethylene_NN
        10_CD -_: lauryl_NN ether_NN )_) ._.
        The_DT data_NNS in_IN this_DT report_NN are_VBP consistent_JJ with_IN a_DT scenario_NN
        in_IN which_WDT intracellular_NN Golgi_NNP /_NN ER_NNP localization_NN of_IN sα_NN 
        i_NNP 2_CD reflects_VBZ its_PRP$ rapid_JJ degradation_NN rather_RB
        than_IN specific_JJ targeting_VBG to_TO a_DT subcellular_NN organelle_NN ._.
        Particularly_RB compelling_JJ is_VBZ the_DT similarity_NN in_IN subcellular_NN
        localization_NN of_IN α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP and_CC sα_NN 
        i_NNP 2_CD (_( Figure_NN 8_CD )_) ._. In_IN addition_NN ,_, the_DT use_NN of_IN
        proteasome_NN inhibitors_NNS (_( Figures_NNS 7_CD and_CC 9_CD )_) suggest_VBP that_DT sα_NN 
        i_NNP 2_CD is_VBZ degraded_JJ by_IN a_DT proteasome_NN pathway_NN ._.
        The_DT observed_VBN intracellular_NN membrane_NN (_( ER_NNP )_) localization_NN and_CC
        proteasome_NN inhibitor-induced_JJ juxtanuclear_NN aggregate_JJ
        accumulation_NN (_( aggresome_NN )_) is_VBZ consistent_JJ with_IN that_DT reported_VBD
        for_IN other_JJ proteins_NNS being_VBG degraded_JJ by_IN such_JJ a_DT pathway_NN [_NN 18_CD 24_CD
        ]_NN ._. When_WRB treated_VBN with_IN proteasome_NN inhibitors_NNS ,_, overexpressed_JJ
        wild_JJ type_NN α_NN 
        i_NNP 2_CD also_RB accumulates_NNS in_IN aggresome-like_JJ
        structures_NNS (_( Figure_NN 7_CD )_) ,_, suggesting_VBG that_IN Gα_NNP may_MD normally_RB be_VB
        degraded_JJ by_IN a_DT proteasome-dependent_JJ pathway_NN ._. However_RB ,_,
        over-expression_JJ of_IN βγ_NN prevents_VBZ ALLN-induced_NNP juxtanuclear_NN
        accumulations_NNS of_IN α_NN 
        i_NNP 2_CD but_CC not_RB sα_NN 
        i_NNP 2_CD (_( Figure_NN 9_CD )_) ._. Although_IN little_JJ is_VBZ known_VBN
        regarding_VBG degradative_JJ pathways_NNS for_IN G_NNP proteins_NNS ,_, sα_NN 
        i_NNP 2_CD and_CC other_JJ mutants_NNS (_( 
        e_SYM ._. g_SYM ._. ,_, α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP )_) may_MD be_VB valuable_JJ tools_NNS for_IN
        defining_VBG such_JJ pathways_NNS ._.
        The_DT data_NNS presented_VBN here_RB argue_VBP against_IN a_DT sequence_NN
        specific_JJ Golgi_NNP membrane_NN targeting_VBG function_NN for_IN the_DT novel_NN 35_CD
        amino_JJ acid_NN sequence_NN found_VBD in_IN sα_NN 
        i_NNP 2_CD ._. The_DT novel_NN sequence_NN of_IN sα_NN 
        i_NNP 2_CD is_VBZ not_RB sufficient_JJ to_TO direct_VB other_JJ
        proteins_NNS to_TO Golgi_NNP /_NN ER_NNP membranes_NNS ._. These_DT 35_CD amino_JJ acids_NNS did_VBD
        not_RB change_VB the_DT cytoplasmic_JJ localization_NN of_IN GFP_NNP (_( Figure_NN 5_LS )_) ._.
        Similarly_RB ,_, a_DT recent_JJ report_NN showed_VBD that_IN the_DT sα_NN 
        i_NNP 2_CD 35_CD amino_JJ acids_NNS were_VBD unable_JJ to_TO retain_VB
        a_DT secreted_JJ protein_NN in_IN intracellular_NN membranes_NNS and_CC did_VBD not_RB
        affect_VB localization_NN of_IN a_DT nuclear_JJ protein_NN [_NN 4_CD ]_NN ._. However_RB ,_,
        in_IN addition_NN to_TO causing_VBG rapid_JJ degradation_NN ,_, one_CD cannot_NN rule_NN
        out_IN that_IN the_DT 35_CD amino_JJ acid_NN sequence_NN of_IN sα_NN 
        i_NNP 2_CD functions_NNS somehow_RB as_IN part_NN of_IN a_DT Golgi_NNP
        targeting_VBG motif_NN in_IN the_DT context_NN of_IN other_JJ regions_NNS of_IN α_NN 
        i_NNP 2_CD ,_, as_IN suggested_VBN [_NN 4_CD ]_NN ._. Other_JJ
        researchers_NNS have_VBP described_VBN a_DT specific_JJ Golgi_NNP membrane_NN
        localization_NN of_IN sα_NN 
        i_NNP 2_CD [_NN 4_CD ]_NN ;_: in_IN contrast_NN ,_, the_DT results_NNS
        presented_VBN in_IN this_DT report_NN always_RB show_NN a_DT much_RB more_JJR disperse_NN
        subcellular_NN localization_NN of_IN sα_NN 
        i_NNP 2_CD to_TO intracellular_NN membranes_NNS consistent_JJ
        with_IN staining_VBG of_IN both_DT Golgi_NNP and_CC ER_NNP ._. The_DT reason_NN for_IN this_DT
        difference_NN in_IN localization_NN is_VBZ unclear_JJ ._. Interestingly_RB ,_, in_IN
        the_DT other_JJ study_NN ,_, the_DT authors_NNS found_VBD that_DT deletion_NN of_IN a_DT
        proline-rich_JJ sequence_NN corresponding_JJ to_TO sα_NN 
        i_NNP 2_CD amino_JJ acids_NNS 348_CD -_: 359_CD (_( Figure_NN 1_LS )_)
        changed_VBN localization_NN of_IN sα_NN 
        i_NNP 2_CD from_IN Golgi_NNP membranes_NNS to_TO a_DT more_JJR
        diffuse_NN localization_NN throughout_IN intracellular_NN membranes_NNS [_NN 4_CD
        ]_NN ._. However_RB ,_, mutation_NN of_IN proline_NN residues_NNS to_TO alanines_NNS
        failed_VBD to_TO affect_VB sα_NN 
        i_NNP 2_CD localization_NN [_NN 4_CD ]_NN ._. Thus_RB ,_, little_JJ
        evidence_NN exists_VBZ to_TO support_VB a_DT specific_JJ membrane_NN targeting_VBG
        role_NN for_IN the_DT novel_NN sα_NN 
        i_NNP 2_CD sequence_NN ._.
        βγ_NN was_VBD able_JJ to_TO promote_VB plasma_NN membrane_NN localization_NN of_IN
        sα_NN 
        i_NNP 2_CD (_( Figure_NN 8_CD )_) ._. βγ_NN prevents_VBZ irreversible_JJ
        inactivation_NN of_IN α_NN 
        i_NNP 1_CD ,_, when_WRB measured_VBN 
        in_IN vitro_NN at_IN 37_CD °_NN C_NNP ,_, and_CC slows_VBZ the_DT
        inactivation_NN of_IN α_NN 
        i_NNP 1_CD A_DT 326_CD S_NNP [_NN 10_CD ]_NN ._. Thus_RB ,_, βγ_NN may_MD stabilize_VB
        sα_NN 
        i_NNP 2_CD and_CC α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP allowing_VBG βγ-dependent_JJ [_NN 25_CD 26_CD
        27_CD 28_CD 29_CD ]_NN PM_NNP localization_NN ._. These_DT results_NNS are_VBP also_RB
        consistent_JJ with_IN the_DT possibility_NN that_IN the_DT primary_JJ defect_NN in_IN
        sα_NN 
        i_NNP 2_CD is_VBZ a_DT reduced_VBN ability_NN to_TO interact_NN with_IN
        βγ_NN ;_: Gα_NNP containing_VBG mutations_NNS in_IN known_VBN sites_NNS of_IN contact_NN with_IN
        βγ_NN fail_VB to_TO localize_NN to_TO PM_NNP ,_, but_CC over-expression_JJ of_IN βγ_NN can_MD
        rescue_VB their_PRP$ PM_NNP localization_NN [_NN 28_CD 29_CD ]_NN ._. However_RB ,_, the_DT
        crystal_NN structures_NNS [_NN 30_CD 31_CD ]_NN show_NN that_IN the_DT C-_NNP terminal_NN β_NN 6_CD -_: α_NN 5_CD
        loop_NN /_NN α_NN 5_CD helix_NN region_NN does_VBZ not_RB directly_RB contact_VB βγ_NN ._. Thus_RB ,_, it_PRP
        is_VBZ more_RBR likely_JJ that_IN indeed_RB sα_NN 
        i_NNP 2_CD is_VBZ deficient_NN in_IN binding_JJ to_TO βγ_NN ,_, but_CC
        this_DT effect_NN is_VBZ a_DT consequence_NN of_IN its_PRP$ instability_NN ._. sα_NN 
        i_NNP 2_CD may_MD exist_VB in_IN a_DT state_NN that_WDT does_VBZ not_RB
        interact_NN well_RB with_IN βγ_NN simply_RB because_IN it_PRP is_VBZ in_IN the_DT process_NN
        of_IN being_VBG irreversibly_RB inactivated_JJ [_NN 9_CD 10_CD ]_NN ._. Similarly_RB ,_, α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP appears_VBZ not_RB to_TO be_VB defective_JJ in_IN
        its_PRP$ intrinsic_JJ ability_NN to_TO interact_NN βγ_NN [_NN 10_CD ]_NN ,_, and_CC
        co-expression_JJ of_IN βγ_NN shifts_NNS α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP ,_, like_IN sα_NN 
        i_NNP 2_CD ,_, from_IN intracellular_NN to_TO plasma_NN
        membranes_NNS (_( Figure_NN 8_CD )_) ._.
        What_WP is_VBZ the_DT cellular_JJ function_NN of_IN sα_NN 
        i_NNP 2_CD ?_. The_DT ability_NN of_IN βγ_NN to_TO promote_VB PM_NNP
        localization_NN of_IN sα_NN 
        i_NNP 2_CD raises_VBZ the_DT possibility_NN that_IN
        endogenous_JJ sα_NN 
        i_NNP 2_CD is_VBZ in_IN fact_NN localized_VBN to_TO PM_NNP where_WRB it_PRP
        can_MD interact_NN with_IN GPCRs_NNP and_CC effectors_NNS ._. Future_JJ studies_NNS will_MD
        test_VB the_DT potential_NN of_IN sα_NN 
        i_NNP 2_CD ,_, when_WRB co-expressed_JJ with_IN βγ_NN ,_, to_TO
        productively_RB interact_NN with_IN receptors_NNS and_CC effectors_NNS ._.
        However_RB ,_, this_DT possibility_NN is_VBZ viewed_VBN as_IN unlikely_JJ for_IN several_JJ
        reasons_NNS ._. First_LS ,_, others_NNS have_VBP shown_VBN that_IN in_IN COS-_NNP 7_CD cells_NNS
        endogenous_JJ sα_NN 
        i_NNP 2_CD is_VBZ not_RB detected_VBN at_IN PM_NNP but_CC only_RB found_VBD
        intracellularly_RB [_NN 3_CD 4_CD ]_NN ,_, although_IN one_CD cannot_NN rule_NN out_IN that_IN
        a_DT small_JJ but_CC functionally_RB significant_JJ fraction_NN of_IN sα_NN 
        i_NNP 2_CD reaches_VBZ the_DT PM_NNP ._. Second_JJ ,_, the_DT extreme_JJ
        C-_NNP termini_NN of_IN Gα_NNP are_VBP critical_JJ sites_NNS for_IN interaction_NN with_IN
        GPCRs_NNP [_NN 32_CD ]_NN ,_, and_CC the_DT novel_JJ C-_NNP terminal_NN sequence_NN found_VBD in_IN
        sα_NN 
        i_NNP 2_CD would_MD be_VB predicted_VBN to_TO disrupt_VB
        productive_JJ interactions_NNS with_IN GPCRs_NNP ._. Third_NNP ,_, even_RB though_IN βγ_NN
        can_MD promote_VB PM_NNP localization_NN of_IN sα_NN 
        i_NNP 2_CD in_IN the_DT overexpression_NN system_NN
        described_VBD here_RB ,_, sα_NN 
        i_NNP 2_CD remains_VBZ less_RBR stable_JJ than_IN α_NN 
        i_NNP 2_CD (_( Figure_NN 9_CD )_) ,_, suggesting_VBG that_IN such_JJ
        instability_NN may_MD also_RB impair_VB productive_JJ interactions_NNS with_IN
        GPCRs_NNP ._.
        On_IN the_DT other_JJ hand_NN ,_, unknown_JJ protein_NN (_( s_VBZ )_) may_MD function_VB to_TO
        stabilize_VB sα_NN 
        i_NNP 2_CD and_CC help_VB direct_JJ it_PRP to_TO Golgi_NNP
        membranes_NNS ._. A_DT specific_JJ combination_NN of_IN β_NN and_CC γ_NN subtypes_NNS may_MD
        play_VB such_PDT a_DT role_NN ;_: however_RB ,_, one_CD thorough_JJ study_NN showed_VBD a_DT lack_NN
        of_IN βγ_NN on_IN Golgi_NNP membranes_NNS of_IN exocrine_NN pancreatic_JJ cells_NNS even_RB
        though_IN a_DT variety_NN of_IN Gα_NNP were_VBD readily_RB detected_VBN in_IN the_DT Golgi_NNP [_NN
        33_CD ]_NN ._. Other_JJ proteins_NNS that_WDT may_MD specifically_RB promote_VB the_DT
        intracellular_NN targeting_VBG of_IN Gα_NNP have_VBP not_RB been_VBN identified_VBN ._.
        It_PRP is_VBZ possible_JJ that_DT sα_NN 
        i_NNP 2_CD functions_NNS as_IN a_DT short-lived_JJ protein_NN
        regulating_VBG some_DT aspect_NN of_IN membrane_NN transport_NN pathways_NNS ;_:
        however_RB ,_, no_DT experiments_NNS to_TO directly_RB support_VB or_CC refute_VB this_DT
        hypothesis_NNS have_VBP been_VBN reported_VBN ._. Instead_RB ,_, it_PRP is_VBZ tempting_JJ to_TO
        speculate_VB that_DT alternative_NN splicing_VBG may_MD be_VB a_DT mechanism_NN to_TO
        regulate_VB cellular_JJ levels_NNS of_IN α_NN 
        i_NNP 2_CD ._. In_IN this_DT model_NN ,_, certain_JJ conditions_NNS
        may_MD favor_VB the_DT formation_NN of_IN sα_NN 
        i_NNP 2_CD compared_VBN to_TO α_NN 
        i_NNP 2_CD ,_, and_CC the_DT resulting_VBG rapid_JJ degradation_NN
        of_IN sα_NN 
        i_NNP 2_CD would_MD decrease_VB the_DT cellular_JJ content_NN
        of_IN α_NN 
        i_NNP 2_CD ._. A_DT precedent_NN for_IN such_JJ alternative_NN
        splicing-dependent_JJ regulation_NN of_IN expression_NN has_VBZ been_VBN
        described_VBN for_IN H-_NNP ras_NNS [_NN 34_CD ]_NN ._. Alternative_NNP splicing_VBG occurs_VBZ in_IN
        H-_NNP ras_NNS ,_, and_CC the_DT alternative_NN spliced_JJ form_NN is_VBZ predicted_VBN to_TO
        encode_NN an_DT unstable_JJ transcript_NN and_CC a_DT protein_NN product_NN that_WDT
        lacks_VBZ the_DT ability_NN to_TO oncogenically_RB transform_VB cells_NNS ._. A_DT
        mutation_NN was_VBD identified_VBN that_IN abolishes_NNS the_DT alternatively_RB
        spliced_JJ form_NN ,_, and_CC this_DT mutation_NN leads_VBZ to_TO an_DT increase_NN in_IN
        H-_NNP ras_NNS expression_NN and_CC transforming_VBG ability_NN ._. Thus_RB ,_, it_PRP was_VBD
        demonstrated_VBN that_DT alternative_NN splicing_VBG is_VBZ a_DT mechanism_NN that_IN
        cells_NNS use_VBP to_TO control_VB expression_NN of_IN H-_NNP ras_NNS [_NN 34_CD ]_NN ._.
        Alternative_NNP splicing_VBG may_MD similarly_RB play_VB an_DT important_JJ role_NN
        in_IN regulating_VBG expression_NN of_IN α_NN 
        i_NNP 2_CD ._. Testing_NNP of_IN this_DT idea_NN will_MD require_VB a_DT
        comparison_NN of_IN sα_NN 
        i_NNP 2_CD and_CC α_NN 
        i_NNP 2_CD transcript_NN levels_NNS ,_, and_CC an_DT analysis_NN of_IN
        whether_IN relative_JJ expression_NN is_VBZ affected_VBN in_IN response_NN to_TO
        physiological_JJ changes_NNS ,_, such_JJ as_IN extracellular_NN stimuli_NNS or_CC
        cell_NN differentiation_NN ._.
      
      
        Conclusions_NNP
        In_IN summary_NN ,_, the_DT results_NNS presented_VBN here_RB demonstrate_VB that_DT
        sα_NN 
        i_NNP 2_CD ,_, a_DT novel_NN splice_NN variant_NN of_IN α_NN 
        i_NNP 2_CD ,_, is_VBZ rapidly_RB degraded_JJ when_WRB expressed_VBD
        in_IN cells_NNS ._. Such_JJ instability_NN is_VBZ consistent_JJ with_IN known_VBN
        structure-function_JJ data_NNS regarding_VBG the_DT importance_NN of_IN the_DT
        C-_NNP terminus_JJ of_IN Gα_NNP subunits_NNS ._. The_DT observed_VBN intracellular_NN
        localization_NN of_IN sα_NN 
        i_NNP 2_CD is_VBZ due_JJ ,_, at_IN least_JJS in_IN part_NN ,_, to_TO its_PRP$
        instability_NN ._. Moreover_RB ,_, the_DT data_NNS presented_VBN in_IN this_DT study_NN
        argue_VBP against_IN the_DT novel_JJ C-_NNP terminus_JJ of_IN sα_NN 
        i_NNP 2_CD functioning_VBG as_IN a_DT specific_JJ Golgi_NNP
        targeting_VBG motif_NN ._.
        In_IN addition_NN ,_, similarly_RB to_TO sα_NN 
        i_NNP 2_CD ,_, an_DT α_NN 
        i_NNP 2_CD mutant_JJ ,_, α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP ,_, previously_RB demonstrated_VBN to_TO be_VB
        unstable_JJ 
        in_IN vitro_NN ,_, displays_VBZ a_DT defect_NN in_IN
        plasma_NN membrane_NN localization_NN when_WRB expressed_VBD in_IN cells_NNS ._. These_DT
        results_NNS suggest_VBP that_IN both_DT sα_NN 
        i_NNP 2_CD and_CC α_NN 
        i_NNP 2_CD A_DT 327_CD S_NNP may_MD prove_VB valuable_JJ in_IN future_JJ
        studies_NNS of_IN mechanisms_NNS of_IN degradation_NN of_IN Gα_NNP ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Materials_NNS
          Cell_NNP culture_NN reagents_NNS were_VBD obtained_VBN from_IN Mediatech_NNP ._.
          [_NN 9_CD ,_, 10_CD -_: 3_CD H_NNP ]_NN palmitic_JJ acid_NN ,_, [_NN 9_CD ,_, 10_CD -_: 3_CD H_NNP ]_NN myristic_JJ acid_NN ,_, and_CC 35_CD S_NNP
          Express_NNP labeling_VBG mix_NN were_VBD from_IN NEN_NNP ._.
          Acetyl-leucyl-leucyl-norleucinal_NNP (_( ALLN_NNP )_) and_CC MG-_NNP 132_CD were_VBD
          from_IN Calbiochem_NNP ._. The_DT EE_NNP monoclonal_NN antibody_NN was_VBD a_DT gift_NN
          from_IN H_NNP ._. Bourne_NNP ._. Other_JJ reagents_NNS were_VBD obtained_VBN from_IN Fisher_NNP
          and_CC Sigma_NNP ._.
        
        
          Expression_NNP plasmids_NNS
          EE-α_NNP 
          i_NNP 2_CD -_: pcDNAI_NN was_VBD obtained_VBN from_IN H_NNP ._. Bourne_NNP
          (_( UCSF_NNP )_) ._. In_IN this_DT plasmid_NN ,_, mouse_NN α_NN 
          i_NNP 2_CD cDNA_NN contains_VBZ the_DT EE_NNP epitope_NN
          sequence_NN EEYMPTE_NNP at_IN codons_NNS 166_CD to_TO 172_CD [_NN 11_CD ]_NN ._. Mouse_NNP sα_NN 
          i_NNP 2_CD cDNA_NN was_VBD provided_VBN by_IN E_NNP ._. Borrelli_NNP
          (_( Strasbourg_NNP )_) in_IN the_DT plasmid_NN pSVsGi_NN 2_CD ._. sα_NN 
          i_NNP 2_CD was_VBD excised_VBN from_IN pSVsGi_NN 2_CD using_VBG
          EcoRI_NNP and_CC SmaI_NNP and_CC subcloned_JJ into_IN the_DT EcoRI_NNP and_CC EcoRV_NNP
          sites_NNS of_IN pcDNAI_NN to_TO produce_VB sα_NN 
          i_NNP 2_CD -_: pcDNAI_NN ._. EE-tagged_NNP sα_NN 
          i_NNP 2_CD was_VBD constructed_VBN by_IN subcloning_VBG a_DT
          EcoRI-BglII_NNP fragment_NN from_IN EE-α_NNP 
          i_NNP 2_CD -_: pcDNAI_NN into_IN sα_NN 
          i_NNP 2_CD -_: pcDNAI_NN ._. EE-tagged_NNP α_NN 
          i_NNP 2_CD A_DT 327_CD S-_NNP pcDNAI_NN was_VBD obtained_VBN from_IN J_NNP ._.
          Morales_NNP (_( UCSF_NNP )_) ._. EE-tagged_NNP α_NN 
          i_NNP 2_CD (_( 1_CD -_: 331_CD )_) -_: pcDNA_NN 3_CD was_VBD constructed_VBN by_IN
          by_IN PCR_NNP amplification_NN of_IN the_DT coding_VBG region_NN for_IN the_DT amino_JJ
          acids_NNS 1_CD to_TO 331_CD of_IN α_NN 
          i_NNP 2_CD using_VBG the_DT T_NN 7_CD primer_NN as_IN the_DT 5_CD '_POS
          primer_NN and_CC 5_CD '_POS -_: ccggctcgagtcacttggtgtcggtggcgcatg-_NN 3_CD '_POS as_IN the_DT
          3_CD '_POS primer_NN and_CC using_VBG EE-α_NNP 
          i_NNP 2_CD -_: pcDNA_NN 3_CD as_IN the_DT template_NN ._. The_DT PCR_NNP
          amplified_VBN product_NN was_VBD digested_VBN with_IN HindIII_NNP and_CC XhoI_NNP and_CC
          subcloned_JJ into_IN the_DT correspondingly_RB digested_VBN EE-α_NNP 
          i_NNP 2_CD -_: pcDNA_NN 3_CD ._. GFP-sα_NNP 
          i_NNP 2_CD 35_CD aa_NN was_VBD constructed_VBN by_IN PCR_NNP
          amplification_NN of_IN the_DT coding_VBG region_NN for_IN the_DT C-_NNP terminal_NN 35_CD
          amino_JJ acids_NNS of_IN sα_NN 
          i_NNP 2_CD using_VBG the_DT 5_CD '_POS primer_NN
          5_CD '_POS -_: cgcagatctagaaaactttttaga-_NN 3_CD '_POS and_CC the_DT 3_CD '_POS primer_NN
          5_CD '_POS -_: cgcaagcttactcaaggcacggaatc-_NN 3_CD '_'' ._. The_DT PCR_NNP fragment_NN was_VBD
          digested_VBN with_IN BglII_NNP and_CC HindIII_NNP and_CC subcloned_JJ into_IN the_DT
          correspondingly_RB digested_VBN pEGFP-C_JJ 1_CD (_( Clontech_NNP )_) ._. α_NN 
          i_NNP 2_CD (_( 1_CD -_: 10_CD )_) -_: GFP_NNP was_VBD constructed_VBN by_IN
          annealing_VBG the_DT complementary_JJ oligonucleotides_NNS
          5_CD '_POS -_: ctagcaccatgggctgcaccgtgtcggccgaggacaag-_NN 3_CD '_POS and_CC
          5_CD '_POS -_: ccggcttgtcctcggacacggtgcagcccatggtg-_NN 3_CD '_POS (_( corresponding_JJ
          to_TO amino_JJ acids_NNS 1_CD -_: 10_CD of_IN α_NN 
          i_NNP 2_LS )_) and_CC ligating_VBG into_IN AgeI-NheI_NNP
          digested_VBN pEGFP-N_JJ 1_CD ._. Human_JJ β_NN 
          1_CD -_: pCMV_NN 5_CD and_CC bovine_JJ γ_NN 
          2_CD -_: pcDNAI_NN have_VBP been_VBN described_VBN [_NN 35_CD ]_NN
          ._.
        
        
          Cell_NNP culture_NN and_CC transfection_NN
          BHK_NNP ,_, HEK_NNP 293_CD ,_, and_CC COS-_NNP 7_CD cells_NNS were_VBD cultured_JJ in_IN DMEM_NNP
          containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN ._. Transfections_NNP were_VBD
          performed_VBN in_IN 6_CD -_: well_RB plates_NNS or_CC 6_CD cm_NN culture_NN dishes_NNS using_VBG
          Lipofectamine_NNP (_( GibcoBRL_NNP )_) or_CC FuGene_NNP 6_CD (_( Roche_NNP )_) according_VBG to_TO
          the_DT manufacturer_NN 's_POS protocol_NN ._.
        
        
          Immunofluorescence_NNP localization_NN
          Cells_NNP were_VBD transfected_JJ in_IN 6_CD -_: well_RB plates_NNS with_IN 1_CD μg_NN of_IN
          the_DT indicated_VBN expression_NN plasmid_NN ._. In_IN experiments_NNS where_WRB β_NN 
          1_CD and_CC γ_NN 
          2_CD expression_NN plasmids_NNS were_VBD
          co-transfected_JJ with_IN α_NN 
          i_NNP 2_CD or_CC sα_NN 
          i_NNP 2_CD ,_, the_DT amounts_NNS of_IN α_NN ,_, β_NN ,_, and_CC γ_NN
          plasmids_NNS used_VBN were_VBD 0_CD ._. 7_CD ,_, 0_CD ._. 2_CD ,_, and_CC 0_CD ._. 1_CD μg_NN ,_, respectively_RB ._. 24_CD
          h_NN after_IN transfection_NN ,_, cells_NNS were_VBD replated_JJ onto_IN glass_NN
          coverslips_NNS and_CC grown_VBN for_IN an_DT additional_JJ 24_CD h_NN before_IN fixing_VBG
          in_IN methanol_NN at_IN -_: 20_CD °_NN C_NNP for_IN 20_CD min_NN ._. Cells_NNP were_VBD washed_VBN with_IN
          PBS_NNP and_CC then_RB incubated_JJ in_IN blocking_VBG buffer_NN consisting_VBG of_IN
          TBS_NNP (_( 50_CD mM_NN Tris_NNP ,_, pH_NN 7_CD ._. 5_CD ,_, 150_CD mM_NN NaCl_NNP )_) with_IN 1_CD %_NN Triton_NNP
          X-_NNP 100_CD and_CC 2_CD ._. 5_CD %_NN nonfat_JJ milk_NN ._. Coverslips_NNP were_VBD then_RB
          incubated_JJ in_IN blocking_VBG buffer_NN containing_VBG 20_CD μg_NN /_NN ml_NN EE_NNP
          monoclonal_NN antibody_NN for_IN 1_CD h_NN ._. For_IN dual_JJ localization_NN
          experiments_NNS ,_, a_DT 1_CD :_: 1000_CD dilution_NN of_IN a_DT rabbit_NN polyclonal_NN
          anti-β-coatomer_JJ protein_NN (_( β-_NN COP_NNP )_) antibody_NN (_( Affinity_NNP
          BioReagents_NNP )_) or_CC a_DT 1_CD :_: 200_CD dilution_NN of_IN a_DT rabbit_NN polyclonal_NN
          anti-protein_JJ disulfide_NN isomerase_NN (_( PDI_NNP )_) antibody_NN
          (_( StressGen_NNP Biotechnologies_NNP )_) was_VBD included_VBN with_IN the_DT EE_NNP
          mouse_NN monoclonal_NN ._. Following_VBG washes_NNS with_IN blocking_VBG buffer_NN ,_,
          cells_NNS were_VBD incubated_JJ in_IN a_DT 1_CD :_: 100_CD dilution_NN of_IN the_DT indicated_VBN
          secondary_JJ antibody_NN ,_, either_CC Alexa_NNP Fluor_NNP 488_CD or_CC 594_CD goat_NN
          anti-mouse_JJ (_( Molecular_NNP Probes_NNP )_) or_CC Texas_NNP Red_NNP donkey_NN
          anti-mouse_JJ (_( Jackson_NNP Immunoresearch_NNP )_) or_CC Alexa_NNP Fluor_NNP 488_CD
          goat_NN anti-rabbit_JJ (_( Molecular_NNP Probes_NNP )_) ,_, for_IN 30_CD min_NN ._. The_DT
          coverslips_NNS were_VBD washed_VBN and_CC mounted_VBN on_IN glass_NN slides_NNS with_IN
          Prolong_NNP Antifade_NNP reagent_NN (_( Molecular_NNP Probes_NNP ,_, Eugene_NNP ,_, OR_NNP )_) ,_,
          and_CC microscopy_NN was_VBD performed_VBN with_IN an_DT Olympus_NNP BX_NNP 60_CD
          microscope_NN equipped_VBN with_IN a_DT Sony_NNP DKC-_NNP 5000_CD digital_JJ camera_NN ._.
          A_DT minimum_NN of_IN 50_CD cells_NNS were_VBD examined_VBN for_IN each_DT
          transfection_NN ._. Transfections_NNP were_VBD repeated_VBN and_CC
          representative_NN pictures_NNS were_VBD taken_VBN of_IN cells_NNS displaying_VBG a_DT
          typical_JJ expression_NN pattern_NN for_IN each_DT transfection_NN ._. Only_RB
          cells_NNS displaying_VBG low_JJ to_TO intermediate_JJ levels_NNS of_IN expression_NN
          were_VBD utilized_JJ ._. Images_NNP were_VBD processed_VBN with_IN Adobe_NNP
          Photoshop_NNP ._.
        
        
          Subcellular_NNP Fractionation_NNP
          Soluble_NNP and_CC particulate_NN fractions_NNS were_VBD isolated_VBN as_RB
          previously_RB described_VBD [_NN 29_CD ]_NN ._. BHK_NNP or_CC COS-_NNP 7_CD cells_NNS were_VBD
          transfected_JJ in_IN 6_CD cm_NN plates_NNS with_IN 3_CD μg_NN of_IN the_DT indicated_VBN
          expression_NN plasmid_NN ._. 24_CD h_NN after_IN transfection_NN ,_, the_DT cells_NNS
          were_VBD transferred_VBN to_TO 10_CD -_: cm_NN plates_NNS and_CC grown_VBN for_IN another_DT 24_CD
          h_NN ._. Cells_NNP were_VBD washed_VBN with_IN phosphate-buffered_JJ saline_NN and_CC
          then_RB lysed_JJ in_IN 0_CD ._. 5_CD ml_NN hypotonic_JJ lysis_NNS buffer_NN by_IN 10_CD
          passages_NNS through_IN a_DT 27_CD -_: gauge_VB needle_NN ._. Cells_NNP were_VBD
          centrifuged_JJ at_IN 200_CD ×_NN g_SYM for_IN 5_CD min_NN to_TO pellet_NN nuclei_NN and_CC
          intact_JJ cells_NNS ,_, and_CC the_DT supernatant_NN was_VBD then_RB centrifuged_JJ at_IN
          150_CD ,_, 000_CD ×_NN g_SYM for_IN 20_CD min_NN to_TO obtain_VB soluble_JJ and_CC particulate_NN
          fractions_NNS ._. Fractions_NNP were_VBD resolved_VBN by_IN 12_CD %_NN SDS-PAGE_NNP ,_,
          transferred_VBN onto_IN PVDF-Plus_NNP (_( Micron_NNP Separations_NNP ,_, Inc_NNP )_) and_CC
          probed_JJ with_IN EE_NNP monoclonal_NN antibody_NN ._. Bands_NNP were_VBD visualized_JJ
          by_IN chemiluminescence_NN ._.
        
        
          Metabolic_NNP labeling_VBG and_CC immunoprecipitation_NN
          COS-_NNP 7_CD cells_NNS were_VBD transfected_JJ in_IN 6_CD cm_NN plates_NNS with_IN 3_CD μg_NN
          of_IN the_DT indicated_VBN expression_NN plasmid_NN ._. 24_CD h_NN after_IN
          transfection_NN ,_, cells_NNS were_VBD replated_JJ into_IN 6_CD cm_NN plates_NNS ._. For_IN
          fatty_NN acid_NN labeling_VBG experiments_NNS [_NN 36_CD ]_NN ,_, one_CD transfection_NN
          was_VBD replated_JJ into_IN two_CD 6_CD cm_NN plates_NNS ._. For_IN 35_CD S_NNP labeling_VBG
          experiments_NNS ,_, cells_NNS from_IN two_CD or_CC three_CD identical_JJ
          transfections_NNS were_VBD combined_VBN before_IN replating_VBG in_IN multiple_JJ
          6_CD cm_NN plates_NNS ._. Incubation_NNP with_IN radioisotope_NN was_VBD then_RB
          performed_VBN 48_CD h_NN after_IN transfection_NN ._.
          For_IN fatty_NN acid_NN labeling_VBG ,_, cells_NNS in_IN a_DT 6_CD cm_NN dish_NN were_VBD
          incubated_JJ with_IN 1_CD ml_NN of_IN DMEM_NNP containing_VBG 10_CD %_NN dialyzed_JJ fetal_JJ
          bovine_JJ serum_NN ,_, 5_CD mM_NN sodium_NN pyruvate_NN ,_, and_CC [_NN 9_CD ,_, 10_CD -_:
          3_CD H_NNP ]_NN palmitic_JJ acid_NN (_( 1_CD mCi_NN /_NN ml_NN )_) or_CC [_NN 9_CD ,_, 10_CD -_: 3_CD H_NNP ]_NN myristate_NN (_( 0_CD ._. 5_LS
          mCi_NN /_NN ml_NN )_) for_IN 2_CD h_NN ._. For_IN 35_CD S_NNP pulse-chase_JJ labeling_VBG ,_, cells_NNS in_IN a_DT
          6_CD cm_NN dish_NN were_VBD washed_VBN with_IN DMEM_NNP (_( without_IN methionine_NN )_) ,_, and_CC
          then_RB incubated_JJ in_IN DMEM_NNP (_( without_IN methionine_NN )_) containing_VBG
          10_CD %_NN dialyzed_JJ fetal_JJ bovine_JJ serum_NN at_IN 37_CD °_NN C_NNP for_IN 1_CD h_NN ._. Next_JJ ,_,
          cells_NNS were_VBD incubated_JJ in_IN DMEM_NNP (_( without_IN methionine_NN )_)
          containing_VBG 10_CD %_NN dialyzed_JJ fetal_JJ bovine_JJ serum_NN and_CC 0_CD ._. 1_CD mCi_NN /_NN ml_NN
          35_CD S_NNP Express_NNP mix_NN for_IN 10_CD min_NN ._. After_IN the_DT 10_CD min_NN pulse_NN
          labeling_VBG ,_, cells_NNS were_VBD either_CC immediately_RB lysed_JJ (_( see_VB below_IN )_)
          or_CC washed_VBN with_IN normal_JJ growth_NN media_NNS and_CC then_RB "_'' chased_VBD "_'' by_IN
          incubation_NN in_IN normal_JJ growth_NN media_NNS for_IN the_DT indicated_VBN
          times_NNS ._.
          Fatty_NNP acid_NN labeled_VBN and_CC 35_CD S_NNP methionine_NN /_NN cysteine_NN labeled_VBD
          samples_NNS were_VBD then_RB identically_RB processed_VBN by_IN
          immunoprecipitation_NN ._. Cells_NNP were_VBD washed_VBN once_RB with_IN ice-cold_JJ
          PBS_NNP and_CC lysed_JJ in_IN 1_CD ml_NN of_IN Extraction_NNP buffer_NN (_( 50_CD mM_NN HEPES_NNP ,_,
          pH_NN 8_CD ,_, 50_CD mM_NN NaCl_NNP ,_, 10_CD μM_NN β-mercaptoethanol_JJ ,_, 1_CD %_NN Triton_NNP
          X-_NNP 100_CD ,_, 1_CD %_NN sodium_NN cholate_NN ,_, 1_CD mM_NN PMSF_NNP ,_, 2_CD μg_NN /_NN ml_NN leupeptin_NN ,_,
          and_CC 2_CD μg_NN /_NN ml_NN aprotinin_NN )_) ._. Cell_NNP extracts_NNS were_VBD tumbled_VBN for_IN 1_CD
          h_NN at_IN 4_CD °_NN C_NNP ,_, and_CC nuclei_NN and_CC insoluble_JJ material_NN were_VBD removed_VBN
          by_IN microcentrifugation_NN at_IN 16_CD ,_, 000_CD ×_NN g_SYM for_IN 3_CD min_NN ._. Samples_NNP
          were_VBD adjusted_VBN to_TO 0_CD ._. 5_CD %_NN SDS_NNP ._. 10_CD μg_NN of_IN EE_NNP antibody_NN was_VBD
          added_VBN ,_, and_CC the_DT samples_NNS were_VBD tumbled_VBN for_IN 2_CD h_NN at_IN 4_CD °_NN C_NNP ._. Next_JJ ,_,
          20_CD μl_NN of_IN Protein_NNP A_DT /_NN G_NNP PLUS_NNP agarose_NN (_( Santa_NNP Cruz_NNP
          Biotechnology_NNP ,_, Santa_NNP Cruz_NNP ,_, CA_NNP )_) was_VBD added_VBN ,_, and_CC the_DT sample_NN
          was_VBD tumbled_VBN overnight_JJ at_IN 4_CD °_NN C_NNP ._. The_DT sample_NN was_VBD centrifuged_JJ
          for_IN 30_CD s_VBZ at_IN 200_CD ×_NN g_SYM to_TO pellet_NN the_DT beads_NNS ._. The_DT supernatant_NN
          was_VBD discarded_VBN ,_, and_CC the_DT beads_NNS were_VBD washed_VBN 3_CD times_NNS with_IN 1_CD
          ml_NN Extraction_NNP buffer_NN ._. SDS-PAGE_NNP sample_NN buffer_NN containing_VBG
          10_CD mM_NN DTT_NNP was_VBD added_VBN to_TO the_DT washed_VBN beads_NNS ,_, and_CC the_DT samples_NNS
          were_VBD heated_JJ at_IN 65_CD °_NN C_NNP for_IN 1_CD min_NN (_( 3_CD H_NNP fatty_NN acid_NN labeled_VBD
          samples_NNS )_) or_CC boiled_VBD for_IN 5_CD min_NN (_( 35_CD S_NNP methionine_NN /_NN cysteine_NN
          labeled_VBD samples_NNS )_) ._. An_DT aliquot_NN was_VBD analyzed_VBN by_IN 10_CD %_NN
          SDS-PAGE_NNP ._. Gels_NNP were_VBD incubated_JJ for_IN 20_CD min_NN in_IN an_DT aqueous_JJ
          solution_NN of_IN 50_CD %_NN methanol_NN /_NN 10_CD %_NN acetic_JJ acid_NN ,_, followed_VBN by_IN 10_CD %_NN
          ethanol_NN /_NN 10_CD %_NN acetic_JJ acid_NN for_IN 20_CD min_NN ,_, and_CC ,_, finally_RB ,_, Amplify_NNP
          (_( Amersham_NNP )_) for_IN 20_CD min_NN ._. Gels_NNP were_VBD dried_VBN and_CC subjected_VBN to_TO
          fluorography_NN at_IN -_: 80_CD °_NN C_NNP using_VBG Hyperfilm_NNP MP_NNP (_( Amersham_NNP )_) ._. For_IN
          35_CD S_NNP pulse-chase_JJ experiments_NNS ,_, intensity_NN of_IN each_DT labeled_VBN
          band_NN was_VBD quantitated_JJ by_IN densitometry_NN ._. Results_NNS were_VBD
          analyzed_VBN with_IN GraphPad_NNP Prizm_NNP software_NN to_TO determine_VB a_DT
          half-life_NN ._.
        
      
    
  
